Make your products visible globally with Elite Membership.
I agree to the terms and conditions
Existing User?
Sign In with Email
Remember Me Forgot Password?
New User?
Enter your registered Email ID to get reset password.
Elite Member
Individual Register
GHENT, BELGIUM: Merck Serono, the biopharmaceutical division of Merck KGaA, and Ablynx have further expanded their relationship through a multi-year research alliance that could lead to at least four co-discovery and co-development collaborations. Both partners will jointly select disease targets against which this group will develop Nanobodies, up to in vivo proof-of-principle. The dedicated group will focus on the discovery and development of Nanobodies against a number of targets across multiple disease areas. The collaboration will span all of Merck Serono’s core research and development fields, including oncology, immuno-oncology, immunology and neurology.
“This is a very exciting expansion of our partnership with Merck Serono, building on the success of our existing collaborations and allowing us to exploit the broad and powerful applicability of our Nanobody platform with a partner with whom we have successfully worked for over five years. The new alliance is an early stage discovery initiative, which allows the companies to rapidly explore the potential of novel targets across a range of therapeutic areas and to determine which programme should be prioritised for later stage development. It is a very interesting model that could create substantial value for both parties and one which we believe could be applicable for us in other partnerships,” said Dr Edwin Moses, Chairman and CEO, Ablynx.
© Worldofchemicals News
Login
LEHIGH VALLEY, US: Air Products will add three new independent directors to its Board of Directors and will commence a search to identify a ...
TOKYO, JAPAN: Toray Industries Inc has agreed to purchase the entire stake at $16.75 per share (total of $584 million) in Zoltek Companies Inc, engagi ...
OBERHAUSEN, GERMANY: Chemical manufacturer Oxea is expanding its portfolio of higher alcohols with 3-methylbutanol (isoamyl alcohol), a versatile inte ...
HOUSTON, US: Clariant, a world leader in Specialty Chemicals, opened its new global headquarters for Oil and Mining Services business unit in The Wood ...
WASHINGTON, US: From mercury to pesticides, Americans are exposed daily to environmental chemicals that could harm reproductive health, said the natio ...
WASHINGTON DC, US: Use of a particular type of titanium dioxide, a common ingredient in cosmetics, food products, toothpaste and sunscreen, could redu ...
Stay updated with the latest chemical industry trends and innovations.
Verification Code has been sent to
Please enter the Verification Code below to verify your Email Address.If you cannot see the email from "noreply@worldofchemicals.com" in your inbox,make sure to check your SPAM Folder